In the discovery stage of a project accurate assessment on pharmacokinetics and metabolism must be available as early as possible as it eventually contributes to the ultimate success or failure of the compound. Optimization of drug absorption, distribution, metabolism, and excretion (ADME) parameters continues to play an important role to ensure that the exposure is sufficient to achieve proof of concept, efficacy and safety of the New Chemical Entity (NCE). Aravali Pharma has expertise in providing quality solutions to your pharmacokinetics and drug metabolism issues. Our experts provide consultation on data analysis, data interpretation, issue resolution, strategic planning and due diligence for ADME and PK studies.
We offer services and consultancy with respect to the preclinical lead optimization and development in: